Spanish OWL Genomics presents a HEPATOchip for diagnosis of non-alcoholic steatohepatitis (NASH)
08-Apr-2005 -
OWL Genomics developed the first DNA chip concerning diagnosis and prognosis of non-alcoholic steatohepatitis (NASH), allowing the discrimination between normal steatosis and NASH predisposed subjects.
The HEPATOCHIP has been developed in collaboration with the Hepatology Services of the Clinic ...
cirrhosis
diseases
Expression
+6